This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jan;142(1):176-8.

doi: 10.1053/j.gastro.2011.11.011. Epub 2011 Nov 21.

Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?

Edouard Louis¹, Julián Panés

Affiliations

PMID: 22115630
DOI: 10.1053/j.gastro.2011.11.011

Comment

Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?

Edouard Louis et al. Gastroenterology. 2012 Jan.

. 2012 Jan;142(1):176-8.

doi: 10.1053/j.gastro.2011.11.011. Epub 2011 Nov 21.

Authors

Edouard Louis¹, Julián Panés

Affiliation

¹ University Hospital CHU of Liège, Liège, Belgium.

PMID: 22115630
DOI: 10.1053/j.gastro.2011.11.011

No abstract available

PubMed Disclaimer

Comment on

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Reinisch W, Sandborn WJ, Hommes DW, D'Haens G, Hanauer S, Schreiber S, Panaccione R, Fedorak RN, Tighe MB, Huang B, Kampman W, Lazar A, Thakkar R. Reinisch W, et al. Gut. 2011 Jun;60(6):780-7. doi: 10.1136/gut.2010.221127. Epub 2011 Jan 5. Gut. 2011. PMID: 21209123 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science